Chenodeoxycholic Acid: UDCA Impurity A and Starting Material
Share
Chenodeoxycholic acid (CDCA) sits on both sides of UDCA documentation. It is the impurity a UDCA buyer checks on the first page of a certificate, and it is also, in most industrial routes, the material UDCA is made from. Both facts come from the same difference between the two molecules: a single hydroxyl group, pointing in a different direction.
That single difference also produces one of the more confusing details in bile-acid paperwork — each substance is the other's impurity A. If you have ever read "impurity A" on a specification and had to work out which molecule was meant, this is why.
Two monographs, two opposite impurity letters
Chenodeoxycholic acid has its own European Pharmacopoeia monograph (1189), separate from the UDCA monograph (1275). Both list related substances with letters, and the letters do not describe fixed molecules — they are assigned relative to whichever monograph they appear in.
The result is a neat reversal at position A:
| Impurity letter | In the UDCA monograph (1275) | In the CDCA monograph (1189) |
|---|---|---|
| A | Chenodeoxycholic acid — limit 1.0% | Ursodeoxycholic acid — limit 1% |
| B | Cholic acid — limit 0.5% | Cholic acid — limit 0.5% |
| C | Lithocholic acid — limit 0.1% | Lithocholic acid — limit 0.1% |
Position A is reciprocal; positions B and C happen to be shared. So when a specification says "impurity A", the meaning depends entirely on which product's monograph it is from. A certificate that names the impurity as well as the letter removes the ambiguity in one word; one that does not is worth a question back to the supplier.
The full lettered set on the UDCA side — A through I, with chemical names and CAS numbers — is laid out in the nine lettered EP impurities of UDCA.
Why the two molecules are so close
UDCA and CDCA are both 24-carbon bile acids with the same formula, the same molecular weight, and hydroxyl groups at the same two positions. They differ at C-7 alone: CDCA carries a 7α-hydroxyl, UDCA a 7β-hydroxyl. Nothing else changes.
One stereocentre is a small difference on paper and a large one in practice. It means the two have similar polarity, similar chromatographic behaviour, and similar everything — which is exactly why they are the pair that gets confused, both by readers of a certificate and by a method that is not quite good enough.
CDCA as the starting material for UDCA
Most industrial UDCA starts from CDCA. The typical route is short to describe and demanding to run:
The middle molecule is 7-ketolithocholic acid (7-KLCA, CAS 4651-67-6), which is also UDCA's EP impurity F and, separately, an intermediate in obeticholic acid synthesis. It is worth knowing under all three of those names — the same molecule arrives on a desk depending on whether the person on the other side is a quality chemist, a process chemist or a buyer. We cover that identity in the 7-oxo intermediate, 7-KLCA.
Where the reduction is imperfect, material that should have ended as the 7β product stays on the 7α side or returns to it. That leftover is impurity A. The substrate and the principal impurity are the same molecule, which is the single most useful thing to understand about why the UDCA limit for chenodeoxycholic acid sits where it does.
The CDCA monograph in numbers
Chenodeoxycholic acid is not only an input to UDCA — it is a monographed active substance in its own right, and is bought and sold as such. Its own specification is set out below.
| Parameter | Ph. Eur. requirement |
|---|---|
| Chemical name | 3α,7α-dihydroxy-5β-cholan-24-oic acid |
| CAS | 474-25-9 |
| Content (dried substance) | 99.0% to 101.0% |
| Appearance | White or almost white powder |
| Specific optical rotation | +11.0° to +13.0° (dried substance) |
| Related substances — UDCA (impurity A) | Not more than 1% |
| Related substances — cholic acid (impurity B) | Not more than 0.5% |
| Related substances — lithocholic acid (impurity C) | Not more than 0.1% |
| Any other impurity | Not more than 0.25% |
| Loss on drying | Not more than 1.5% |
| Sulphated ash | Not more than 0.1% |
Two features deserve a note. First, the CDCA monograph allows a higher loss on drying (1.5%) than the UDCA monograph does (1.0%) — the two substances are not interchangeable as powders, and specifications should not be copied across them.
Second, CDCA shows polymorphism, and the monograph says so. That matters when a customer compares melting behaviour or dissolution across lots: a different polymorph is not a different substance, but it can behave differently under a press or in a formulation step.
What changed in 2022: TLC out, HPLC in
For years, the related-substances test in monograph 1189 was a thin-layer chromatography method. A revised version was published as a draft in 2019 and took effect in January 2022, replacing the TLC test with two liquid-chromatography methods using a differential refractometer (HPLC-RI).
The practical effect for a buyer is a documentation question. If a supplier's certificate still cites a TLC related-substances method for CDCA and does not show a liquid-chromatography result, the certificate is being produced against an obsolete method. That is a specific, checkable question to put to a supplier — and a much better one than "are you compliant?"
Reporting, identification and qualification thresholds
Beyond the individual limits, the general Ph. Eur. monograph for substances for pharmaceutical use sets thresholds that determine when an impurity must be reported, identified and qualified. For CDCA these are based on the maximum daily dose:
- Reporting threshold: above 0.05%
- Identification threshold: above 0.10%
- Qualification threshold: above 0.15%
These are separate from the related-substances limits in the product monograph. A peak can be below a product limit and still cross a reporting threshold; the two frameworks answer different questions. Confusing them is a common source of disagreement between a supplier and an incoming-goods laboratory.
The two test panels side by side
Because the two substances are monographed separately, the differences between their specifications are few in number and worth keeping in view. The table below sets the main comparable parameters against each other.
| Parameter | UDCA (monograph 1275) | CDCA (monograph 1189) |
|---|---|---|
| Content (dried substance) | 99.0% to 101.0% | 99.0% to 101.0% |
| Specific optical rotation | +58.0° to +62.0° | +11.0° to +13.0° |
| Loss on drying | Not more than 1.0% | Not more than 1.5% |
| Sulphated ash | Not more than 0.1% | Not more than 0.1% |
| Polymorphism | — | Stated in the monograph |
| Impurity A | CDCA, not more than 1.0% | UDCA, not more than 1% |
| Impurity C | Lithocholic acid, not more than 0.1% | Lithocholic acid, not more than 0.1% |
The assay range is the same, which is often taken to mean the rest of the panel is the same. It is not. Rotation is the clearest example: the two ranges are far enough apart that a single measurement distinguishes the substances, which is why it is a first-line identity test rather than a formality.
The monograph and its reference standards are published by the EDQM. Broader principles for classifying, reporting and qualifying impurities come from the ICH quality guidelines. A customer working to the United States Pharmacopeia will hold you to a different published panel again, maintained by the USP. Knowing which of the three a specification is written against is the first question worth asking.
Questions buyers ask
Is chenodeoxycholic acid the same as UDCA impurity A?
Yes. In the UDCA monograph, chenodeoxycholic acid is impurity A, with a limit of 1.0%. The reverse is also true: in the CDCA monograph, UDCA is impurity A, limited to 1%.
Is CDCA used to make UDCA?
In most industrial routes, yes. CDCA is oxidised to the 7-oxo intermediate (7-KLCA) and then reduced stereoselectively to the 7β configuration of UDCA.
What is the CDCA limit for UDCA as an impurity?
Not more than 1%, under the CDCA monograph. Cholic acid is capped at 0.5% and lithocholic acid at 0.1%, with any other impurity at 0.25%.
What is the specific optical rotation of chenodeoxycholic acid?
+11.0° to +13.0°, measured on the dried substance. This is well below the +58.0° to +62.0° range of UDCA, so rotation is a fast way to tell the two apart.
Did the CDCA related-substances method change?
Yes. A 2019 draft took effect in January 2022, replacing thin-layer chromatography with two liquid-chromatography methods. Certificates citing only a TLC related-substances method are working from the older edition.
Can a COA's specification table be reused between CDCA and UDCA?
No. Loss on drying, optical rotation and impurity limits all differ between the two monographs. A table copied across products is a documented risk, not a shortcut.
If you buy either molecule
CDCA and UDCA are one stereocentre apart, and their documentation is one letter apart. The confusion that follows is avoidable, but only if the documents name what they mean.
Ask for the impurity to be named alongside its letter, the related-substances method to be dated to the current monograph, and the assay to be stated on the dried basis. If you source both molecules, keep the two specification lines separate on the same certificate rather than merged. Our chenodeoxycholic acid grade and the related chenodeoxycholic acid oxide (7-KLCA) are described with those parameters, and if you are comparing the two against your own acceptance criteria you can request a quotation. For the wider limit structure on the UDCA side, see a full UDCA specification.
This article describes pharmacopoeial requirements and analytical interpretation only. It is not a statement of therapeutic use, and it does not set out commercial guarantees. Always work from the pharmacopoeia edition in force at the time of your release.
Frequently asked questions
Is CDCA the same thing as UDCA impurity A?
Chemically yes: chenodeoxycholic acid is impurity A in the UDCA monograph. The name changes with the context. Sold as a product it is CDCA with its own specification; printed as a line on a UDCA certificate it is impurity A with a limit. Same molecule, two different documents.
Why does the CDCA limit on a UDCA certificate matter?
Because it is a statement about process control. CDCA is the immediate precursor in the isomerisation, and the limit shows how completely the route drives the reaction and purifies afterwards. A buyer who reads nothing else on the certificate can still learn a lot from that one line and its trend across batches.
Can CDCA intended as a starting material carry a looser specification than CDCA sold as a product?
Often yes, because purification happens downstream. What the buyer should ask for is not a tighter number but the impurity profile itself, since UDCA-specific impurities behave differently in the route than generic ones. A starting material is qualified for what it contributes to the synthesis, not for standing on its own.
Does a CDCA COA predict the impurity A result in the finished UDCA?
No. Purification between the starting material and the API changes the picture entirely. The CDCA file supports the regulatory chain of the route; it does not transfer limits forward. Any supplier who offers it as a substitute for the API impurity data is selling the wrong document.
What documentation links a CDCA batch to a UDCA regulatory file?
Traceability: the batch linkage showing which CDCA went into which campaign, the specification the material was released against, and a description of the route. The audit question is not whether the purity was good but whether the connection can be shown on paper years later.
When qualifying CDCA as a starting material, which tests matter more than for the finished product?
Identity and impurity origin. A starting material is chosen for the impurities it will carry into the route, so the named-impurity table and the origin statements weigh more than a headline assay. Ask which impurities the downstream process was designed to purge, and ask for the evidence.